SIGRID’s Glucose Stabiliser Demonstrates Clinical Efficacy and U.S. Commercial Momentum Amid Growing Demand for Metabolic Health Solutions
Stockholm, Sweden – June 9, 2025. SIGRID, the Swedish healthtech innovator behind the patented...
Stockholm, Sweden – June 9, 2025. SIGRID, the Swedish healthtech innovator behind the patented...
Titled “The latest in APAC’s metabolic health landscape“, the webinar is available to watch on demand here. Registration to watch...